Johannes Schmid

9PUBLICATIONS
184CO-AUTHORS
AllergyPsychology of ageingRespiratory diseasesPsychosocial aspects of childbirth and perinatal mental healthNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2026
Efficacy and Safety of Intralymphatic Immunotherapy With Grass Allergoid and Microcrystalline Tyrosine: A Double-Blind Randomised Placebo-Controlled Trial.

|Jan 09, 2026
Adult reference values for spirometry, body plethysmography and diffusing capacity adjusted for sex, age, weight, height or arm span - the Danish lung function material (DALFUMAT) study.

Jann Mortensen, Lars Kristensen, Mathias Munkholm

|Nov 10, 2025
Low-Dose Intralymphatic Immunotherapy for Grass Pollen Allergy is Both Safe and Effective.

Bjarke Hviid-Vyff, Søren Helbo Skaarup, Amber Duin

|Feb 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma.

Kjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh

|Jan 28, 2025
Idiopathic subglottic stenosis in a 32-year-old pregnant woman.

Bo Toennesen, Thomas Kjærgaard, Johannes Martin Schmid

|Jun 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohort.

Eve Denton, Mark Hew, Matthew J Peters

Pageof 2

Frequent Collaborators

5 joint publications

Hans Jürgen Hoffmann

2 joint publications

Søren Helbo Skaarup

2 joint publications

Charlotte Suppli Ulrik

2 joint publications

Celeste Porsbjerg